Nisa Investment Advisors
CGEM icon

Nisa Investment Advisors’s Cullinan Oncology CGEM Stock Holding History

Nisa Investment Advisors’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.3K Sell
1,442
-4,358
-75% -$64.7K ﹤0.01% 2109
2026
Q1 		$82.4K Buy
5,800
+5,500
+1,833% +$70.7K ﹤0.01% 1497
2025
Q4 		$3.1K Sell
300
-72
-19% -$649 ﹤0.01% 2538
2025
Q3 		$2.21K Buy
372
+92
+33% +$674 ﹤0.01% 2598
2025
Q2 		$2.11K Buy
280
+180
+180% +$1.45K ﹤0.01% 2596
2025
Q1 		$757 Sell
100
-45
-31% -$432 ﹤0.01% 2707
2024
Q4 		$1.77K Sell
145
-84
-37% -$1.21K ﹤0.01% 2528
2024
Q3 		$3.83K Buy
229
+64
+39% +$1.14K ﹤0.01% 2270
2024
Q2 		$2.88K Buy
165
+27
+20% +$575 ﹤0.01% 2335
2024
Q1 		$2.35K Buy
138
+21
+18% +$324 ﹤0.01% 2207
2023
Q4 		$1.19K Sell
117
-24
-17% -$213 ﹤0.01% 2234
2023
Q3 		$1.28K Buy
141
+25
+22% +$260 ﹤0.01% 2366
2023
Q2 		$1.25K Buy
116
+107
+1,189% +$1.14K ﹤0.01% 2406
2023
Q1 		$0 Sell
9
-13,891
-100% -$153K ﹤0.01% 2551
2022
Q4 		$147K Sell
13,900
-3,341
-19% -$40.6K ﹤0.01% 1436
2022
Q3 		$222K Buy
17,241
+3,341
+24% +$45K ﹤0.01% 1246
2022
Q2 		$178K Buy
+13,900
New +$158K ﹤0.01% 1340

Other funds holding CGEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Nisa Investment Advisors's CGEM Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Cullinan Oncology (CGEM) stake by 75% in Q2 2026, selling an estimated $64.7K and leaving 1,442 shares worth $26.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

Nisa Investment Advisors first reported a position in CGEM in Q2 2022 and has held it in 17 quarters since. The position peaked at $222K in Q3 2022. 56 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Nisa Investment Advisors held 1,442 shares of Cullinan Oncology worth $26.3K as of Q2 2026.
  • Nisa Investment Advisors sold 4,358 Cullinan Oncology shares in Q2 2026, an estimated $64.7K.
  • Cullinan Oncology made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2109 holding.
  • Nisa Investment Advisors first reported a position in Cullinan Oncology in Q2 2022 and has held it in 17 quarters since.
  • Nisa Investment Advisors's Cullinan Oncology position peaked at $222K in Q3 2022.
  • 56 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.